Search results
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 hour agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 1 day agoOne of those prongs is improving immune responses, a pillar that stars Moderna-shared cancer vaccine...
Promising trial data for Moderna's skin cancer vaccine sends stock rising
Quartz· 1 day agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 3 hours agoThe new data in patients with advanced melanoma, a type of skin cancer, shows that three years after...
Immunotherapy drug may keep colon cancer patients cancer-free after surgery
UPI· 1 day agoDoctors in Britain say that an immunotherapy drug, given before surgery, can help many more colon ...
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...
Lack of insurance may prevent Americans from accessing best cancer drugs
United Press International via Yahoo News· 1 day agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. But the drugs,...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 24 hours agoThe vaccines use messenger RNA — essential molecules that help convert the information in DNA to...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 6 days agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 1 day agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...